Howard Burris III
Sarah Cannon

Last Updated On 4/14/2022 2:01:00 PM
This is a disclosure report of the user financial relationships with for-profit health care companies.
All relationships are considered compensated unless otherwise noted. Relationships are self-held unless otherwise noted.

Employment
Company: HCA Healthcare / Sarah Cannon
Recipient: You

Leadership
Company: HCA Healthcare / Sarah Cannon
Recipient: You

Stock and Other Ownership Interests
Company: HCA Healthcare / Sarah Cannon
Recipient: You

Honoraria
No Relationships to Disclose

Consulting or Advisory Role
No Relationships to Disclose

Speakers' Bureau
No Relationships to Disclose

Research Funding
Company: Roche/Genentech
Recipient: Your Institution
Company: Bristol-Myers Squibb
Recipient: Your Institution
Company: Incyte
Recipient: Your Institution
Company: AstraZeneca
Recipient: Your Institution
Company: MedImmune
Recipient: Your Institution
Company: Macrogenics
Recipient: Your Institution
Company: Novartis
Recipient: Your Institution
Company: Boehringer Ingelheim
Recipient: Your Institution
Company: Lilly
Recipient: Your Institution
Company: Seattle Genetics
Recipient: Your Institution
Company: Merck
Recipient: Your Institution
Company: Agios
Recipient: Your Institution
Company: Jounce Therapeutics
Recipient: Your Institution
Company: Moderna Therapeutics
Recipient: Your Institution
Company: CytomX Therapeutics
Recipient: Your Institution
Company: GlaxoSmithKline
Recipient: Your Institution
Company: Verastem
Recipient: Your Institution
Company: Tesaro
Recipient: Your Institution
Company: BioMed Valley Discoveries
Recipient: Your Institution
Company: TG Therapeutics
Recipient: Your Institution
Company: Vertex
Recipient: Your Institution
Company: eFFECTOR Therapeutics
Recipient: Your Institution
Company: Janssen
Recipient: Your Institution
Company: Gilead Sciences
Recipient: Your Institution
Company: BioAtla
Recipient: Your Institution
Company: CicloMed
Recipient: Your Institution
Company: Harpoon therapeutics
Recipient: Your Institution
Company: Arch
Recipient: Your Institution
Company: Arvinas
Recipient: Your Institution
Company: Revolution Medicines
Recipient: Your Institution
Company: Array BioPharma
Recipient: Your Institution
Company: Bayer
Recipient: Your Institution
Company: Kymab
Recipient: Your Institution
Company: Pfizer
Recipient: Your Institution
Company: Takeda/Millennium
Recipient: Your Institution
Company: Foundation Medicine
Recipient: Your Institution
Company: EMD Serono
Recipient: Your Institution
Company: ARMO BioSciences
Recipient: Your Institution
Company: CALGB
Recipient: Your Institution
Company: Hengrui Therapeutics
Recipient: Your Institution
Company: XBiotech
Recipient: Your Institution
Company: Zymeworks
Recipient: Your Institution
Company: Coordination Pharmaceuticals
Recipient: Your Institution
Company: NGM Biopharmaceuticals
Recipient: Your Institution
Company: Gossamer Bio
Recipient: Your Institution
Company: Ryvu Therapeutics
Recipient: Your Institution
Company: BioTheryX
Recipient: Your Institution
Company: Abbvie
Recipient: Your Institution
Company: BeiGene
Recipient: Your Institution

Patents, Royalties, Other Intellectual Property
No Relationships to Disclose

Expert Testimony
No Relationships to Disclose

Travel, Accommodations, Expenses
No Relationships to Disclose

Other Relationship
No Relationships to Disclose

(OPTIONAL) Uncompensated Relationships
Company: Bayer
Recipient: Your Institution
Company: GRAIL
Recipient: Your Institution
Company: Novartis
Recipient: Your Institution
Company: Vincerx Pharma
Recipient: Your Institution
Company: AstraZeneca
Recipient: Your Institution
Company: Incyte
Recipient: Your Institution
Company: Bristol-Myers Squibb
Recipient: Your Institution
Company: Boehringer Ingelheim
Recipient: Your Institution
Company: TG Therapeutics
Recipient: Your Institution

(OPTIONAL) Open Payments Link
Open Payments URL: https://openpaymentsdata.cms.gov/physician/201030/summary